Pharmacokinetic Drug-drug Interaction Study Between RaltEgravir and CITALopram in Healthy Subjects (RECITAL).

Trial Profile

Pharmacokinetic Drug-drug Interaction Study Between RaltEgravir and CITALopram in Healthy Subjects (RECITAL).

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 20 Nov 2013

At a glance

  • Drugs Citalopram (Primary) ; Raltegravir (Primary)
  • Indications HIV-1 infections; Major depressive disorder
  • Focus Pharmacokinetics
  • Acronyms RECITAL
  • Most Recent Events

    • 20 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top